N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology
JR Moffett, B Ross, P Arun, CN Madhavarao… - Progress in …, 2007 - Elsevier
The brain is unique among organs in many respects, including its mechanisms of lipid
synthesis and energy production. The nervous system-specific metabolite N-acetylaspartate …
synthesis and energy production. The nervous system-specific metabolite N-acetylaspartate …
Radiation-induced brain injury: a review
D Greene-Schloesser, ME Robbins, AM Peiffer… - Frontiers in …, 2012 - frontiersin.org
Approximately 100,000 primary and metastatic brain tumor patients/year in the US survive
long enough (> 6 months) to experience radiation-induced brain injury. Prior to 1970, the …
long enough (> 6 months) to experience radiation-induced brain injury. Prior to 1970, the …
Inflammatory cytokines in experimental and human stroke
KL Lambertsen, K Biber… - Journal of Cerebral Blood …, 2012 - journals.sagepub.com
Inflammation is a hallmark of stroke pathology. The cytokines, tumor necrosis factor (TNF),
interleukin (IL)-1, and IL-6, modulate tissue injury in experimental stroke and are therefore …
interleukin (IL)-1, and IL-6, modulate tissue injury in experimental stroke and are therefore …
Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury
S Di Giovanni, V Movsesyan… - Proceedings of the …, 2005 - National Acad Sciences
Traumatic brain injury (TBI) causes neuronal apoptosis, inflammation, and reactive
astrogliosis, which contribute to secondary tissue loss, impaired regeneration, and …
astrogliosis, which contribute to secondary tissue loss, impaired regeneration, and …
Detection of the ischemic penumbra using pH-weighted MRI
The classic definition of the ischemic penumbra is a hypoperfused region in which
metabolism is impaired, but still sufficient to maintain cellular polarization. Perfusion-and …
metabolism is impaired, but still sufficient to maintain cellular polarization. Perfusion-and …
Middle cerebral artery occlusion model in rodents: methods and potential pitfalls
F Liu, LD McCullough - BioMed Research International, 2011 - Wiley Online Library
A variety of animal models have been developed for modeling ischemic stroke. The middle
cerebral artery occlusion (MCAO) model has been utilized extensively, especially in rodents …
cerebral artery occlusion (MCAO) model has been utilized extensively, especially in rodents …
TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion
F Liu, DP Schafer, LD McCullough - Journal of neuroscience methods, 2009 - Elsevier
Considerable debate exists in the literature on how best to measure infarct damage and at
what point after middle cerebral artery occlusion (MCAO) infarct is histologically complete …
what point after middle cerebral artery occlusion (MCAO) infarct is histologically complete …
Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance …
The pattern and role of brain plasticity in stroke recovery has been incompletely
characterized. Both ipsilesional and contralesional changes have been described, but it …
characterized. Both ipsilesional and contralesional changes have been described, but it …
Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental stroke
VR Venna, J Li, MD Hammond… - European Journal of …, 2014 - Wiley Online Library
Metformin is currently the first‐line treatment drug for type 2 diabetes. Metformin is a well‐
known activator of AMP‐activated protein kinase (AMPK). In experimental studies, metformin …
known activator of AMP‐activated protein kinase (AMPK). In experimental studies, metformin …
In vivo small animal imaging: Current status and future prospects
The use of small animal models in basic and preclinical sciences constitutes an integral part
of testing new pharmaceutical agents prior to commercial translation to clinical practice …
of testing new pharmaceutical agents prior to commercial translation to clinical practice …